ANDROGENETIC ALOPECIA (AGA)
Clinical trials for ANDROGENETIC ALOPECIA (AGA) explained in plain language.
Never miss a new study
Get alerted when new ANDROGENETIC ALOPECIA (AGA) trials appear
Sign up with your email to follow new studies for ANDROGENETIC ALOPECIA (AGA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Baldness breakthrough? new pill promises hair regrowth in men
Disease control Not yet recruitingThis study tests an oral medication called N1087 (minoxidil) for male pattern hair loss. About 372 men aged 18 to 60 with moderate balding will take either the drug or a placebo daily for 24 weeks. The goal is to see if the pill increases hair density and is safe to use.
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 17, 2026 11:39 UTC
-
One-shot hair fix? new study pits nanofat against daily creams
Disease control Not yet recruitingThis study tests whether a single injection of nanofat (processed fat tissue) can outperform either PRP injections or daily minoxidil 5% for treating male and female pattern baldness. Sixty adults aged 18-50 with confirmed androgenetic alopecia will be enrolled. The goal is to se…
Matched conditions: ANDROGENETIC ALOPECIA (AGA)
Phase: PHASE4 • Sponsor: Assiut University • Aim: Disease control
Last updated May 17, 2026 11:37 UTC